22:22 IST
BSE
Other Announcement
Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals informs shareholders that the Annual Report for FY 2025-26 and the 32nd AGM notice are available on the Company's website.
Novelix Pharmaceuticals Ltd
- Share price
- ₹71.95
- Market cap
- ₹126.7 Cr
- Revenue (annual)
- ₹132.3 Cr
- Net profit (annual)
- ₹2.56 Cr
- P/E (TTM)
- 34.9×Sector 66.8×
- Promoter holding
- 54.29%+4.86% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 2Board Meeting Date 2Management Change 1Financial Results 1Capacity Expansion 1Board Meeting Outcome 1Annual Report 1Annual General Meeting 1
Time
2 announcements with these filters
18:49 IST
BSE
Other Announcement
Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals filed its Statement of Deviation and Variation for the quarter ended June 30, 2026, reporting no deviations in fund utilization.